Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19.

Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19. Am J Respir Crit Care Med. 2020 Sep 15;: Authors: Rappaport SH, Clark JM, Delibert S, Maynard KM, Prasad P, Kaufman DC, Pietropaoli AP, Quill CM, Groth CM PMID: 32931713 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32931713?dopt=Abstract

Source: American Journal of Respiratory and Critical Care Medicine - September 14, 2020 Category: Respiratory Medicine Authors: Rappaport SH, Clark JM, Delibert S, Maynard KM, Prasad P, Kaufman DC, Pietropaoli AP, Quill CM, Groth CM Tags: Am J Respir Crit Care Med Source Type: research

More News: COVID-19 | Respiratory Medicine